Quick Takeaways
- Nicholas A. Saccomano has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $30,479.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Nicholas A. Saccomano
- Location
- Boulder, CO
- Summary
- The estimated net worth of Nicholas A. Saccomano is at least $30,479 dollars as of 03 Apr 2026. Nicholas A. Saccomano is the President and CEO, Director of OnKure Therapeutics, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $30.5K.
- Signature
- /s/ Rogan Nunn, by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Nicholas A. Saccomano and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: OnKure Therapeutics, Inc. ($30,479).
- Past-year value change for that position: -$1,056.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Nicholas A. Saccomano
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | President and CEO, Director | $30,479 | -$1,056 | -3.3% | 01 Apr 2026 |
Insider Transactions Reported by Nicholas A. Saccomano:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.